Health Canada drug identification number

DIN 02516268 — WAKIX 20 MG

WAKIX is a tablet of Pitolisant marketed by KNIGHT THERAPEUTICS INC.. The full Pitolisant monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02516268
Brand name
WAKIX
Active ingredient
Pitolisant
Strength
20 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
KNIGHT THERAPEUTICS INC.
Health Canada status
MARKETED
Drug class
Histamine H3 receptor antagonist/inverse agonist (wake-promoting agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Pitolisant products

DINBrandStrengthFormManufacturerStatus
02516241 WAKIX 5 MG TABLET KNIGHT THERAPEUTICS INC. MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.